REX:NYSEREX American Resources Corporation Analysis
Data as of 2026-04-28 - not real-time
$47.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
REX American Resources is trading at $47.25, well above its DCF‑derived fair value of $18.43, suggesting a significant premium. The stock sits above its 20‑day SMA ($44.87) and 50‑day SMA ($40.68) and is approaching the 200‑day SMA ($33.69), confirming a strong bullish bias. Momentum indicators reinforce this view: the RSI is at 69, edging close to overbought territory, while the MACD line (1.41) sits above its signal (1.33) with a positive histogram, signalling continued upward pressure. Technical support sits at $41.38 and resistance near $48.66, leaving limited upside before a potential pull‑back. Volatility is elevated at 43% over the past 30 days, and volume trends are decreasing, which could foreshadow a slowdown in price advances. Fundamentally, the company posted flat revenue growth (-0.2%) and modest margins (gross 14.4%, operating 10.5%, profit 12.8%). Earnings beat expectations with EPS of $2.50, but forward EPS guidance drops to $2.27, indicating decelerating profitability. The balance sheet is strong, with $376 M cash, only $21 M debt, and a debt‑to‑equity ratio of 3.0, yet the price‑to‑earnings multiple of 18.9 and price‑to‑book of 2.55 reflect a valuation that appears stretched relative to intrinsic estimates. No dividend is paid, removing income‑focused appeal. Overall, the stock’s technical vigor is counterbalanced by overvaluation and modest growth prospects, suggesting caution for investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical setup (RSI 69, MACD bullish)
- Proximity to resistance at $48.66
- Elevated short‑term volatility
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation versus DCF fair value
- Flat revenue growth and declining forward EPS
- High volatility and decreasing volume trend
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong balance sheet with ample cash and low debt
- Absence of dividend reduces total return appeal
- Sector headwinds from regulatory and commodity price dynamics
Key Metrics & Analysis
Financial Health
Revenue Growth-0.20%
Profit Margin12.75%
P/E Ratio18.9
ROE14.13%
ROA5.03%
Debt/Equity3.03
P/B Ratio2.5
Op. Cash Flow$117.8M
Free Cash Flow$18.7M
Technical Analysis
TrendBullish
RSI69.0
Support$41.38
Resistance$48.66
MA 20$44.87
MA 50$40.68
MA 200$33.69
MACDBullish
VolumeDecreasing
Fear & Greed Index89.25
Valuation
Fair Value$18.43
GradeOvervalued
TypeValue
Risk Assessment
Beta0.35
Volatility43.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.